OKYO Pharma (OKYO) Q3 2025 Earnings
OKYO·Reported January 30, 2026·After market close
Diluted EPS came in at $-0.01 (+0.0% YoY), beat the $-0.07 consensus by $0.06.
Diluted EPS
$-0.01beat by $0.06
Consensus: $-0.07
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2025 Earnings FAQ
Common questions about OKYO Pharma's Q3 2025 earnings report.
OKYO Pharma (OKYO) reported Q3 2025 earnings on January 30, 2026 after market close.
OKYO Pharma reported diluted EPS of $-0.01 for Q3 2025.
EPS beat the consensus estimate of $-0.07 by $0.06.
Compared to the same quarter a year prior, diluted EPS grew 0.0% from $-0.01.